Developing a Risk Assessment System of Multidrug-resistant Organisms Infection

CompletedOBSERVATIONAL
Enrollment

917

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

May 1, 2022

Study Completion Date

December 30, 2022

Conditions
Bacterial Infections
Interventions
OTHER

risk factors of infection with multidrug-resistant organisms

"1. General information: age, gender, length of stay in ICU, method of admission, tubes taken at the time of admission, APACHEⅡ score, surgery, laboratory tests (PCT, CRP, WBC), pressure sores, etc.~2. Iatrogenic factors: days of using ventilator, days of using antibacterial drugs, types of antibacterial drugs, use of glucocorticoids, use of immunosuppressants, days of central venous intubation, days of indwelling catheters, days of arterial catheterization, and other indwelling catheters.~3. The patient's own related factors: diagnosis, whether complicated with hypertension or diabetes; whether exist malignant tumor, primary lung infection, hypoproteinemia; whether antibiotic treatment before admission; fever and fever days, whether diarrhea occurs"

Trial Locations (1)

310009

2nd Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou

All Listed Sponsors
lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER

NCT04688216 - Developing a Risk Assessment System of Multidrug-resistant Organisms Infection | Biotech Hunter | Biotech Hunter